CS228142B2 - Preparation of molecular coordinating complex - Google Patents

Preparation of molecular coordinating complex Download PDF

Info

Publication number
CS228142B2
CS228142B2 CS809008A CS900880A CS228142B2 CS 228142 B2 CS228142 B2 CS 228142B2 CS 809008 A CS809008 A CS 809008A CS 900880 A CS900880 A CS 900880A CS 228142 B2 CS228142 B2 CS 228142B2
Authority
CS
Czechoslovakia
Prior art keywords
polymer
cellulose
alcohol
weight
solvent
Prior art date
Application number
CS809008A
Other languages
Czech (cs)
English (en)
Inventor
Stewart T Leslie
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of CS228142B2 publication Critical patent/CS228142B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/05—Alcohols; Metal alcoholates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Materials Engineering (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
CS809008A 1979-12-19 1980-12-18 Preparation of molecular coordinating complex CS228142B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IE2480/79A IE49324B1 (en) 1979-12-19 1979-12-19 Controlled release compositions
IE248179 1979-12-19

Publications (1)

Publication Number Publication Date
CS228142B2 true CS228142B2 (en) 1984-05-14

Family

ID=26319271

Family Applications (1)

Application Number Title Priority Date Filing Date
CS809008A CS228142B2 (en) 1979-12-19 1980-12-18 Preparation of molecular coordinating complex

Country Status (27)

Country Link
US (1) US4366310A (xx)
EP (1) EP0032004B1 (xx)
JP (1) JPS5698201A (xx)
AU (1) AU541246B2 (xx)
BE (1) BE886711A (xx)
CA (1) CA1168230A (xx)
CS (1) CS228142B2 (xx)
DE (1) DE3048028A1 (xx)
DK (1) DK170347B1 (xx)
EG (1) EG14984A (xx)
ES (1) ES497906A0 (xx)
FI (1) FI66623C (xx)
FR (1) FR2474507B1 (xx)
GB (1) GB2067569B (xx)
GR (1) GR72265B (xx)
HU (1) HU188085B (xx)
IE (1) IE49324B1 (xx)
IL (1) IL61677A (xx)
MX (1) MX158088A (xx)
NL (1) NL187401C (xx)
NO (1) NO152846C (xx)
NZ (1) NZ195793A (xx)
PL (1) PL133079B1 (xx)
PT (1) PT72214B (xx)
SU (1) SU1178326A3 (xx)
YU (1) YU40957B (xx)
ZA (1) ZA807716B (xx)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1211266A (en) * 1982-11-12 1986-09-16 Alfred E. Lauchenauer Shaped semi-solid articles
DE3306621A1 (de) * 1983-02-25 1984-08-30 Hoechst Ag, 6230 Frankfurt Verfahren zur herstellung von celluloseethern mit einem dimethoxyethan enthaltenden dispergierhilfsmittel
GB8514665D0 (en) * 1985-06-11 1985-07-10 Eroceltique Sa Oral pharmaceutical composition
GB8613688D0 (en) * 1986-06-05 1986-07-09 Euro Celtique Sa Pharmaceutical composition
ES2058111T3 (es) * 1986-06-10 1994-11-01 Euro Celtique Sa Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) * 1986-10-31 1986-12-03 Euro Celtique Sa Controlled release hydromorphone composition
US5079005A (en) * 1988-06-17 1992-01-07 Gupta Kashmiri L Time release protein
US5055300A (en) * 1988-06-17 1991-10-08 Basic Bio Systems, Inc. Time release protein
US5023080A (en) * 1988-06-17 1991-06-11 Basic Bio Systems, Inc. Time release protein
US5476668A (en) * 1990-08-24 1995-12-19 Shin-Etsu Chemical Co., Ltd. Base for film-coating pharmaceuticals and method for preparing same
NZ260408A (en) 1993-05-10 1996-05-28 Euro Celtique Sa Controlled release preparation comprising tramadol
US5891471A (en) * 1993-11-23 1999-04-06 Euro-Celtique, S.A. Pharmaceutical multiparticulates
KR100354702B1 (ko) * 1993-11-23 2002-12-28 유로-셀티크 소시에떼 아노뉨 약학조성물의제조방법및서방형조성물
US5843480A (en) * 1994-03-14 1998-12-01 Euro-Celtique, S.A. Controlled release diamorphine formulation
GB9422154D0 (en) 1994-11-03 1994-12-21 Euro Celtique Sa Pharmaceutical compositions and method of producing the same
US5965161A (en) 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
AU8532798A (en) * 1997-06-13 1998-12-30 Roland Bodmeier Compounds which delay the release of active substances
PT1041987E (pt) 1997-12-22 2006-07-31 Euro Celtique Sa Forma farmaceutica de dosagem oral, compreendendo uma combinacao de um agonista de opioide e naltrexona
DE19918325A1 (de) 1999-04-22 2000-10-26 Euro Celtique Sa Verfahren zur Herstellung von Arzneiformen mit regulierter Wirkstofffreisetzung mittels Extrusion
RS50407B (sr) 2000-02-08 2009-12-31 Euro-Celtique S.A., Oralne formulacije opijatnog agonista otporne na mehaničke,termičke i/ili hemijske promene fizičkih osobina doznog oblika
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
DK1416842T3 (da) 2001-07-18 2009-03-16 Euro Celtique Sa Farmaceutiske kombinationer af oxycodon og naloxon
US20030044458A1 (en) 2001-08-06 2003-03-06 Curtis Wright Oral dosage form comprising a therapeutic agent and an adverse-effect agent
AU2002324624A1 (en) 2001-08-06 2003-02-24 Euro-Celtique S.A. Sequestered antagonist formulations
US20030068375A1 (en) 2001-08-06 2003-04-10 Curtis Wright Pharmaceutical formulation containing gelling agent
PL367427A1 (en) 2001-08-06 2005-02-21 Euro-Celtique S.A. Opioid agonist formulations with releasable and sequestered antagonist
DE60325567D1 (de) 2002-04-05 2009-02-12 Euro Celtique Sa Matrix für die modifizierte freigabe von aktiven substanzen
PT1551372T (pt) 2002-09-20 2018-07-23 Alpharma Pharmaceuticals Llc Subunidade de sequestração e composições e métodos relacionados
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) 2003-04-21 2011-08-21 Euro Celtique Sa Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
LT1765292T (lt) 2004-06-12 2018-01-10 Collegium Pharmaceutical, Inc. Nuo piktnaudžiavimo apsaugotos vaistų formos
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
ES2600141T3 (es) 2006-06-19 2017-02-07 Alpharma Pharmaceuticals Llc Composiciones farmacéuticas
EP1897543A1 (en) 2006-08-30 2008-03-12 Euro-Celtique S.A. Buprenorphine- wafer for drug substitution therapy
US8623418B2 (en) 2007-12-17 2014-01-07 Alpharma Pharmaceuticals Llc Pharmaceutical composition
JP2010159364A (ja) * 2009-01-09 2010-07-22 Kyoto Univ セルロースの高温での着色を抑制する方法
CN102387802B (zh) 2009-03-10 2016-05-04 欧洲凯尔特公司 包含羟考酮和纳洛酮的立即释放药物组合物
US10668060B2 (en) 2009-12-10 2020-06-02 Collegium Pharmaceutical, Inc. Tamper-resistant pharmaceutical compositions of opioids and other drugs
BR112012028656A2 (pt) 2010-05-10 2016-08-09 Euro Celtique Sa combinação de grânulos carregados ativos com ativos adicionais
NZ603173A (en) * 2010-05-10 2014-10-31 Euro Celtique Sa Manufacturing of active-free granules and tablets comprising the same
MY157673A (en) 2010-05-10 2016-07-15 Euro Celtique Sa Pharmaceutical compositions comprising hydromorphone and naloxone
CN103370058A (zh) 2010-12-22 2013-10-23 普渡制药公司 包覆的抗篡改控制释放剂型
KR101458334B1 (ko) 2010-12-23 2014-11-04 퍼듀 퍼머 엘피 탬퍼 저항성 고체 경구 투여 형태
AP2015008579A0 (en) 2013-02-05 2015-07-31 Purdue Pharma Lp Tamper resistant pharmaceutical formulations
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
NZ716267A (en) 2013-07-23 2017-05-26 Euro Celtique Sa A combination of oxycodone and naloxone for use in treating pain in patients suffering from pain and a disease resulting in intestinal dysbiosis and/or increasing the risk for intestinal bacterial translocation
EP3068397A1 (en) 2013-11-13 2016-09-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
US9737530B1 (en) 2016-06-23 2017-08-22 Collegium Pharmaceutical, Inc. Process of making stable abuse-deterrent oral formulations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264766A (en) * 1877-09-19 1981-04-28 Hoffmann-La Roche Inc. Immunological diagnostic reagents
US2921883A (en) * 1957-05-03 1960-01-19 Smith Kline French Lab Novel coating material for medicaments
US3133863A (en) * 1961-03-10 1964-05-19 Strong Cobb Arner Inc Sustained release therapeutic tablet compositions comprising organic solvent-gelled gums
US3146167A (en) * 1961-10-05 1964-08-25 Smith Kline French Lab Method of preparing sustained release pellets and products thereof
GB1405088A (en) * 1971-06-03 1975-09-03 Mundipharma Ag Slow release formulation
US3988482A (en) * 1971-08-27 1976-10-26 Toyo Hakka Kogyo Kabushiki Kaisha Menthol glycoside, process for preparing the same and method for releasing menthol therefrom
US3818107A (en) * 1972-09-28 1974-06-18 Brook D Chewing gum with sustained flavor release compositions
US3899439A (en) * 1973-03-12 1975-08-12 Hercules Inc Method of preparing aqueous dispersions of hydroxypropyl cellulose
DE2644678A1 (de) * 1976-10-02 1978-04-06 Dynamit Nobel Ag Verfahren zur herstellung funktionalisierter cellulosen
JPS54105223A (en) * 1977-12-29 1979-08-18 Yamanouchi Pharmaceut Co Ltd Coating agent for solid medicine
US4259355A (en) * 1979-03-05 1981-03-31 International Flavors & Fragrances Inc. Chewing gum containing flavor composition and flavor composition therefor
US4226849A (en) * 1979-06-14 1980-10-07 Forest Laboratories Inc. Sustained release therapeutic compositions
US4259314A (en) * 1979-12-10 1981-03-31 Hans Lowey Method and composition for the preparation of controlled long-acting pharmaceuticals

Also Published As

Publication number Publication date
PT72214B (en) 1981-11-02
JPS5698201A (en) 1981-08-07
ES8303489A1 (es) 1983-02-01
ES497906A0 (es) 1983-02-01
IL61677A (en) 1984-10-31
HU188085B (en) 1986-03-28
EP0032004A2 (en) 1981-07-15
YU321080A (en) 1983-06-30
AU6529880A (en) 1981-06-25
CA1168230A (en) 1984-05-29
AU541246B2 (en) 1985-01-03
GB2067569B (en) 1983-09-01
NL8006891A (nl) 1981-07-16
DK170347B1 (da) 1995-08-07
US4366310A (en) 1982-12-28
HUT34891A (en) 1985-05-28
NO803836L (no) 1981-06-22
EP0032004B1 (en) 1985-05-15
ZA807716B (en) 1981-12-30
FR2474507A1 (fr) 1981-07-31
PL133079B1 (en) 1985-05-31
PT72214A (en) 1980-08-01
YU40957B (en) 1986-08-31
NL187401C (nl) 1991-09-16
DE3048028A1 (de) 1981-09-10
NO152846C (no) 1985-11-27
GR72265B (xx) 1983-10-10
DK527680A (da) 1981-08-05
IE792480L (en) 1981-06-19
GB2067569A (en) 1981-07-30
EG14984A (en) 1986-06-30
JPH0225921B2 (xx) 1990-06-06
NO152846B (no) 1985-08-19
PL228573A1 (xx) 1982-07-19
MX158088A (es) 1989-01-06
NZ195793A (en) 1982-09-14
FI66623C (fi) 1984-11-12
FI66623B (fi) 1984-07-31
NL187401B (nl) 1991-04-16
SU1178326A3 (ru) 1985-09-07
EP0032004A3 (en) 1982-07-14
IE49324B1 (en) 1985-09-18
FI803848L (fi) 1981-06-20
FR2474507B1 (fr) 1986-12-26
BE886711A (fr) 1981-06-17
IL61677A0 (en) 1981-01-30

Similar Documents

Publication Publication Date Title
CS228142B2 (en) Preparation of molecular coordinating complex
RU2152802C2 (ru) Твердая фармацевтическая композиция и способ ее получения
FI100219B (fi) Menetelmä farmaseuttisen granulaatin valmistamiseksi
CA1079638A (en) Coated granules of polyacrylic alkali metal salts and method of producing same
HU208785B (en) Process for producing amino acid granules by extrusion
US4151274A (en) Process and composition for the production of suppositories
KR0177493B1 (ko) 단사정계 결정구조를 갖고 감열, 감광 및 감습성이 있는 활성성분을 함유하는 정제의 제조방법
DE112006001853T5 (de) Pharmazeutische Zusammensetzungen, die Clopidogrel-Bisulphat enthalten
WO1999003945A1 (de) Agglomerate zur herstellung eines wässrigen bindemittelsystems
US4184888A (en) Effervescent adhesive-forming product
CA1063023A (en) Particulate compositions for ointment preparation
CA2421769C (en) A compacted 2,2-dibromo-3-nitrilopropionamide
CN106822018A (zh) 一种布洛芬缓释片及其制备方法
CN107550881B (zh) 一种非洛地平缓释片及其制备工艺
DE2050701B2 (de) Verwendung eines pulverfoermigen celluloseaethers als hilfsstoff zur herstellung von leicht zerfallbaren festen arzneiformen
JPH02131434A (ja) 薬剤組成物
GB2192128A (en) Production of pharmaceutical unit dosage forms
JPH10182448A (ja) 圧縮製剤用組成物の製造方法
DE60311796T2 (de) Methode zur verbesserung der oberflächeneigenschaften von tabletten
EA021571B1 (ru) Способ получения таблетированной массы из активных фармацевтических субстанций, имеющих седативное и спазмолитическое действия
CA2259730A1 (en) Sustained release tablets containing bupropion hydrochloride
JP2000007585A (ja) 耐湿性固形製剤及びその製造方法
RU2093500C1 (ru) Способ приготовления пороховой массы при изготовлении пироксилиновых порохов
Khandai et al. Ionotropic Cross-linked Carbo-protein Micro Matrix System: An Approach for Improvement of Drug Release, Compaction and Tableting behavior of Losartan Potassium
Kalaiselvan et al. A SYSTEMATIC APPROACH TO SCALEMUP THE HIGH-SHEAR GRANULATION PROCESS FOR MEBENDAZOLE TABLETS TO ACHIEVE A SCALE-INDEPENDENT DRUG RELEASE